Dr. Munir Ghesani, MD, FACNM, FACR, FSNMMI

Dr. Munir Ghesani, MD, FACNM, FACR, FSNMMI, is a distinguished leader in nuclear medicine, with a career spanning over 25 years in academic practice. He currently serves as the Chief Medical Officer at United Theranostics and as the System Chief of Nuclear Medicine at the Mount Sinai Health System in New York. Additionally, he holds the position of Associate Clinical Professor of Radiology at the Icahn School of Medicine at Mount Sinai.
More Details

Educational Background and Early Career

Dr. Ghesani earned his medical degree from Gujarat University, NHL Medical College in Ahmedabad, India, in 1984. He completed a diagnostic radiology residency in 1988 at the KM School of Postgraduate Medicine and Research, followed by a diagnostic ultrasound fellowship in 1989 at LG Hospital and KM School of Postgraduate Medicine and Research, also in Ahmedabad. Imaging Technology News

Upon moving to the United States, Dr. Ghesani pursued an internal medicine residency at Jersey City Medical Center in New Jersey, completed in 1993. He then undertook a nuclear medicine residency and fellowship at St. Luke’s–Roosevelt Hospital Center in New York, finishing in 1996. Subsequently, he completed a radiology residency at the same institution.

Dr. Ghesani’s comprehensive medical training formed the foundation for a distinguished career in nuclear medicine. He has served in numerous leadership roles, including as System Chief of Nuclear Medicine for the Mount Sinai Health System and Associate Clinical Professor of Radiology at the Icahn School of Medicine at Mount Sinai. His work has significantly contributed to the evolution of nuclear medicine, particularly in oncologic imaging and targeted radionuclide therapies. He is an active participant in multidisciplinary clinical conferences and works closely with the FDA to bring innovative radiotracers into clinical use.

Clinical Excellence and Academic Contributions

Dr. Ghesani is widely recognized for his clinical leadership and academic influence in nuclear medicine and molecular imaging. As System Chief of Nuclear Medicine and Molecular Imaging at the Mount Sinai Health System through June 2024, he played a pivotal role in modernizing nuclear medicine services, promoting interdisciplinary integration, and mentoring emerging leaders in the field.

In his academic role as Associate Clinical Professor of Radiology at the Icahn School of Medicine at Mount Sinai, Dr. Ghesani has helped shape the educational and research landscape for radiology trainees. His clinical and translational research is focused on oncologic imaging and targeted radionuclide therapies, areas in which he has worked closely with the FDA to facilitate the introduction of new radiopharmaceuticals into clinical settings.

Leadership in Professional Societies

Dr. Ghesani’s leadership extends beyond clinical and academic realms into influential roles within prominent positions in professional societies:

  • Society of Nuclear Medicine and Molecular Imaging (SNMMI): He served as the President from June 2022 to June 2023. During his tenure, he focused on increasing consumer outreach, expanding educational offerings, and working with U.S. regulators to streamline the approval of new diagnostic and therapeutic radiopharmaceuticals.
  • American Board of Nuclear Medicine (ABNM): He has served as Chair and Director, contributing to the advancement of nuclear medicine standards and practices.
  • American College of Nuclear Medicine (ACNM): Dr. Ghesani held the position of President, demonstrating his commitment to the field’s growth and development.

His contributions have been recognized with several honors, including the ACNM Personal Best Mentor of the Year award in 2020.

Scholarly Contributions

Dr. Ghesani is a prolific contributor to the scientific community, with over 200 peer-reviewed publications and more than 150 invited presentations at regional, national, and international conferences. His scholarly work spans a wide range of topics in nuclear medicine, with a particular focus on oncologic imaging and theranostics.

In addition to his extensive journal contributions, Dr. Ghesani serves as the Editor-in-Chief of a comprehensive three-part book series, Nuclear Medicine: A Case-Based Approach, published by Jaypee Brothers Medical Publishers. This authoritative work includes 176 clinical cases across three major domains: general nuclear medicine, nuclear cardiology, and PET/CT imaging. The series is a valuable educational resource for trainees, practicing physicians, and technologists, offering insights for both board examination preparation and clinical decision-making.

His recent scholarly leadership includes co-authoring and leading the publication of the article “Evolving Paradigms in Lung Cancer: Latest Trends in Diagnosis, Management, and Radiopharmaceuticals”, featured in the March 2025 issue of Seminars in Nuclear Medicine. This review highlights emerging practices in lung cancer care and advances in diagnostic radiopharmaceuticals, reflecting Dr. Ghesani’s continued commitment to cutting-edge clinical and translational research.

Thought Leadership and Public Engagement

Dr. Ghesani actively shares insights and developments in nuclear medicine through various platforms:

  • Webinars and Lectures: He presented a webinar titled “Theranostic Approaches: Challenges and Opportunities Across the Globe,” highlighting the global landscape of theranostics. SNMMI/ACNM Webinar – Theranostic Approaches: Challenges and Potentials from Training to Practice Across the Globe – SNMMI
  • Industry Collaborations: Dr. Ghesani announced United Theranostics’ successful securing of a $15 million senior debt facility to expand theranostic centers across the U.S., aiming to make advanced cancer treatments more accessible.
  • Professional Recognition: Colleagues have acknowledged his contributions to the field, with Lisa Hazen, R.T.(N), CNMT, FSNMTS, expressing gratitude for his impactful lectures and leadership in nuclear medicine and molecular imaging.
  • (14) Post | LinkedIn

Current Role at United Theranostics

In June 2024, Dr. Ghesani transitioned to United Theranostics as Chief Medical Officer and Medical Director at their Princeton, New Jersey facility. United Theranostics is a leader in outpatient radiopharmaceutical therapy and imaging services, focusing on delivering innovative precision medicine techniques in a patient-centered setting. In his current role, Dr. Ghesani oversees clinical operations, research initiatives, and the integration of cutting-edge theranostic approaches, aiming to expand access to advanced cancer treatments.

Honors and Recognitions

Dr. Ghesani’s contributions have been recognized through numerous awards and honors. He has been named a Fellow of the American College of Nuclear Medicine (2006), the American College of Radiology (2018), and the Society of Nuclear Medicine and Molecular Imaging (2023). His accolades include the ACNM Personal Best Mentor of the Year award in 2020, reflecting his dedication to mentorship and education. He has also been listed among Castle Connolly’s Top Doctors in Nuclear Medicine and recognized in publications such as New York Super Doctors and Marquis Who’s Who in America.

Selected Publications and Media Features

Dr. Ghesani has authored and contributed to numerous publications, reflecting his expertise and thought leadership in nuclear medicine:

He has also been featured in various media outlets and professional platforms:

  • Q&A with Dr. Munir Ghesani, discussing his role and perspectives in nuclear medicine. Mount Sinai Health System
  • Participation in the Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), where he delivered opening remarks and engaged in discussions on advancements in the field. Physician’s Channel

Contact Information

(11) Munir Ghesani MD, FACNM, FACR, FSNMMI | LinkedIn

Dr. Ghesani practices at United Theranostics – Princeton, NJ,

Located at:
8 Forrestal Road South, Suite 201,
Princton, NJ 08540

Phone: (609) 300-2858
Fax: (609) 257-4158

Website: www.unitedtheranostics.com

Dr. Munir Ghesani’s career is a testament to the profound impact that dedicated clinical practice, academic excellence, and visionary leadership can have on the advancement of medical science and patient care.